![](/img/cover-not-exists.png)
Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network metaâanalysis of phase 3 randomized controlled trials
Dhakal, Binod, Narra, Ravi K., Giri, Smith, Szabo, Aniko, Smunt, Timothy L., Ghose, Sanjoy, Pathak, Lakshmi Kant, Aryal, Madan, Hamadani, Mehdi, Chhabra, Saurabh, Janz, Siegfried, DâSouza, Anita, HaJournal:
Cancer
DOI:
10.1002/cncr.32831
Date:
March, 2020
File:
PDF, 573 KB
2020